Works matching DE "MET receptor"

Results: 367

Characterization, Expression and Function of c-MET in Canine Spontaneous Cancers.

Published in:

Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 49, doi. 10.1111/j.1476-5810.2005.0064z.x

By:

Liao, A. T.;
McMahon, M.;
London, C. A.

Publication type:

Article

Immunohistochemical Expression of Hepatocyte Growth Factor Receptor and Epidermal Growth Factor Receptor in Serous Ovarian Tumors.

Published in:

Zagazig University Medical Journal, 2025, v. 31, n. 3, p. 1197, doi. 10.21608/zumj.2025.350021.3777

By:

Mohamed Elarini, Raghda Mahdi;
Nour Elden, Eman Taher;
Mohamed, Reham Sameh;
Said, Nelly Mohamed

Publication type:

Article

c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.

Published in:

European Journal of Gynaecological Oncology, 2015, v. 36, n. 3, p. 255, doi. 10.12892/ejgo2575.2015

By:

Zhuang, X. P.;
Jin, W. W.;
Teng, X. D.;
Yuan, Z. Z.;
Lin, Q. Q.;
Xu, S. T.

Publication type:

Article

Crizotinib changes the metabolic pattern and inhibits ATP production in A549 non-small cell lung cancer cells.

Published in:

Oncology Letters, 2021, v. 21, n. 1, p. N.PAG

By:

Ye, Sa;
Zhou, Hong-Bin;
Chen, Ying;
Li, Kai-Qiang;
Jiang, Shan-Shan;
Hao, Ke

Publication type:

Article

Increase in CD4+FOXP3+ regulatory T cell number and upregulation of the HGF/c-Met signaling pathway during the liver metastasis of colorectal cancer.

Published in:

Oncology Letters, 2020, v. 20, n. 3, p. 2113, doi. 10.3892/ol.2020.11785

By:

Huang, Xiaoming;
Chen, Zexian;
Zhang, Nanrong;
Zhu, Caiyan;
Lin, Xutao;
Yu, Jiandong;
Chen, Zhiping;
Lan, Ping;
Wan, Yunle

Publication type:

Article

Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines.

Published in:

Oncology Letters, 2019, v. 18, n. 3, p. 2977, doi. 10.3892/ol.2019.10643

By:

Wang, Hui-Li;
Liu, Yan-Chun;
Long, Ming-Peng;
Zheng, Chuan;
Yang, Jia-Hui

Publication type:

Article

Hypoxia-inducible factor-1 signaling pathway influences the sensitivity of HCC827 cells to gefitinib.

Published in:

Oncology Letters, 2019, v. 17, n. 4, p. 4034

By:

Jin, Qian;
Zhou, Jianying;
Xu, Xianrong;
Huang, Feihua;
Xu, Weihua

Publication type:

Article

miR-148a-3p suppresses epithelial ovarian cancer progression primarily by targeting c-Met.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6131, doi. 10.3892/ol.2018.8110

By:

Wang, Wen;
Dong, Jing;
Wang, Maoxiu;
Yao, Shujuan;
Tian, Xiangyu;
Cui, Xiujuan;
Fu, Shijie;
Zhang, Shiqian

Publication type:

Article

Prognostic significance of c‑Met, β‑catenin and FAK in patients with hepatocellular carcinoma following surgery.

Published in:

Oncology Letters, 2018, v. 15, n. 3, p. 3796, doi. 10.3892/ol.2018.7733

By:

Gong, Xue-Yi;
Ma, Ning;
Xu, Hong-Xu;
ChEN, Fan;
Huang, Xiao-Hui;
Wang, Qian

Publication type:

Article

High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma.

Published in:

Oncology Letters, 2018, v. 15, n. 1, p. 931, doi. 10.3892/ol.2017.7356

By:

Jiang, Mei;
Zhang, Hui;
Xiao, He;
Zhang, Zhimin;
Que, Dan;
Luo, Jia;
Li, Jian;
Mao, Bijing;
Chen, Yuanyuan;
Lan, Meilin;
Wang, Ge;
Xiao, Hualiang

Publication type:

Article

c-met is overexpressed in type I ovarian cancer: Results of an investigative analysis in a cohort of consecutive ovarian cancer patients.

Published in:

Oncology Letters, 2016, v. 12, n. 3, p. 2001, doi. 10.3892/ol.2016.4895

By:

BATTISTA, MARCO JOHANNES;
SCHMIDT, MARCUS;
JAKOBI, SINA;
COTARELO, CRISTINA;
ALMSTEDT, KATRIN;
HEIMES, ANNE-SOPHIE;
MAKRIS, GEORGIOS-MARIOS;
WEYER, VERONIKA;
LEBRECHT, ANTJE;
HOFFMANN, GERALD;
EICHBAUM, MICHAEL

Publication type:

Article

c-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivo.

Published in:

Oncology Letters, 2016, v. 11, n. 4, p. 2879, doi. 10.3892/ol.2016.4303

By:

YITAO JIA;
GUANGYAO DAI;
JINXI WANG;
XING GAO;
ZHAOLONG ZHAO;
ZHIHUI DUAN;
BIN GU;
WEIGUANG YANG;
JIANHUA WU;
YINGCHAO JU;
MINGXIA WANG;
ZHONGXIN LI

Publication type:

Article

MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET.

Published in:

Oncology Letters, 2014, v. 8, n. 2, p. 891, doi. 10.3892/ol.2014.2184

By:

XIU-JIE SHENG;
ZHEN LI;
MAN SUN;
ZHI-HUI WANG;
DONG-MEI ZHOU;
JIAN-QI LI;
QIN ZHAO;
XIAO-FANG SUN;
QI-CAI LIU

Publication type:

Article

Systemic Treatment of Ewing Sarcoma: Current Options and Future Perspectives.

Published in:

Forum of Clinical Oncology, 2021, v. 12, n. 3, p. 3, doi. 10.2478/fco-2021-0005

By:

Moreno, Jose Duran;
Papageorgiou, Georgios;
Gazouli, Ioanna;
Kyriazoglou, Anastasios

Publication type:

Article

Glucolipotoxic Stress-Induced Mig6 Desensitizes EGFR Signaling and Promotes Pancreatic Beta Cell Death.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 5, p. 627, doi. 10.3390/metabo13050627

By:

Chen, Yi-Chun;
Lutkewitte, Andrew J.;
Basavarajappa, Halesha D.;
Fueger, Patrick T.

Publication type:

Article

Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

Published in:

Oncogene, 2015, v. 34, n. 46, p. 5718, doi. 10.1038/onc.2015.20

By:

Gui, Y;
Yeganeh, M;
Donates, Y-C;
Tobelaim, W-S;
Chababi, W;
Mayhue, M;
Yoshimura, A;
Ramanathan, S;
Saucier, C;
Ilangumaran, S

Publication type:

Article

Targeting the oncogenic Met receptor by antibodies and gene therapy.

Published in:

Oncogene, 2015, v. 34, n. 15, p. 1883, doi. 10.1038/onc.2014.142

By:

Vigna, E;
Comoglio, P M

Publication type:

Article

Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment.

Published in:

Oncogene, 2015, v. 34, n. 2, p. 144, doi. 10.1038/onc.2013.539

By:

Kwon, Y;
Smith, B D;
Zhou, Y;
Kaufman, M D;
Godwin, A K

Publication type:

Article

Cutaneous leucocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma.

Published in:

Clinical & Experimental Dermatology, 2021, v. 46, n. 4, p. 739, doi. 10.1111/ced.14541

By:

Coltart, G. S.;
Sutton, J. E.;
Roche, H. J.;
Sommerlad, M. P.;
Crabb, S. J.;
Healy, E.

Publication type:

Article

The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism.

Published in:

Genes, 2024, v. 15, n. 7, p. 953, doi. 10.3390/genes15070953

By:

Davis, James C.;
Waltz, Susan E.

Publication type:

Article

An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling.

Published in:

Genes, 2023, v. 14, n. 2, p. 517, doi. 10.3390/genes14020517

By:

Hunt, Brian G.;
Fox, Levi H.;
Davis, James C.;
Jones, Angelle;
Lu, Zhixin;
Waltz, Susan E.

Publication type:

Article

c-Met-targeted chimeric antigen receptor T cells inhibit hepatocellular carcinoma cells in vitro and in vivo.

Published in:

Journal of Biomedical Research, 2022, v. 36, n. 1, p. 10, doi. 10.7555/JBR.35.20200207

By:

Xiaochen Huang;
Jiaojiao Guo;
Tao Li;
Lizhou Jia;
Xiaojun Tang;
Jin Zhu;
Qi Tang;
Zhenqing Feng

Publication type:

Article

Differential expression of genes encoding proteins of the HGF/MET system in insulinomas.

Published in:

Diabetology & Metabolic Syndrome, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13098-015-0079-3

By:

De Bernards Murat, Cahuê;
Lopes da Rosa, Paula Waki;
Henriques Zanella Fortes, María Angela;
Corrêa, Luciana;
Cesar Machado, Marcel Cerqueira;
Novak, Estela Maria;
Coelho Siqueira, Sheila Aparecida;
Albergaría Pereira, Maria Adelaide;
Corrêa-Giannella, Maria Lucia;
Giannella-Neto, Daniel;
Rodrigues Giorgi, Ricardo

Publication type:

Article

Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion.

Published in:

OncoTargets & Therapy, 2024, v. 17, p. 79, doi. 10.2147/OTT.S442685

By:

Ouyang, Ganlu;
Shu, Pei;
Xue, Yinyin;
Luo, Feng;
Li, Yan

Publication type:

Article

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 5691, doi. 10.2147/OTT.S219959

By:

Bylicki, Olivier;
Paleiron, Nicolas;
Assié, Jean-Baptiste;
Chouaïd, Christos

Publication type:

Article

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 4869, doi. 10.2147/OTT.S148604

By:

Ayoub, Nehad M.;
Al-Shami, Kamal M.;
Alqudah, Mohammad A.;
Mhaidat, Nizar M.

Publication type:

Article

The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 5919, doi. 10.2147/OTT.S111778

By:

Yong-Xu Jia;
Teng-Fei Li;
Dan-Dan Zhang;
Zong-Min Fan;
Hui-Jie Fan;
Jie Yan;
Li-Juan Chen;
Hong Tang;
Yan-Ru Qin;
Xing-Ya Li

Publication type:

Article

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 5809, doi. 10.2147/OTT.S107946

By:

Yıldız, Yetkin;
Sokmensuer, Cenk;
Yalcin, Suayib

Publication type:

Article

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo.

Published in:

PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199517

By:

Fisher, Matthew;
Lath, Darren L.;
Buckle, Clive H.;
Evans, Holly R.;
Down, Jenny M.;
Lawson, Michelle A.;
Chantry, Andrew D.

Publication type:

Article

Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.

Published in:

PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199024

By:

Li, Weihua;
Zheng, Hongqun;
Xu, Jiankai;
Cao, Shaodong;
Xu, Xiuan;
Xiao, Peng

Publication type:

Article

Expression and Function of c-Met, a Receptor for Hepatocyte Growth Factor, During T-Cell Development.

Published in:

Scandinavian Journal of Immunology, 1998, v. 47, n. 4, doi. 10.1046/j.1365-3083.1998.00324.x

By:

Tamura;
Sugawara;
Tokoro;
Taniguchi;
Fukao;
Nakauchi;
Takahama

Publication type:

Article

MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant.

Published in:

Brain Pathology, 2024, v. 34, n. 3, p. 1, doi. 10.1111/bpa.13198

By:

Liu, Lingyu;
Zhang, Ke‐Nan;
Zhao, Zheng;
Li, Guanzhang;
Chai, Rui‐Chao;
Li, Zhuoqun;
Liu, Xing;
Chen, Jing;
Jiang, Tao

Publication type:

Article

Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.

Published in:

Nature Medicine, 2012, v. 18, n. 7, p. 1118, doi. 10.1038/nm.2819

By:

Kentsis, Alex;
Reed, Casie;
Rice, Kim L;
Sanda, Takaomi;
Rodig, Scott J;
Tholouli, Eleni;
Christie, Amanda;
Valk, Peter J M;
Delwel, Ruud;
Ngo, Vu;
Kutok, Jeffery L;
Dahlberg, Suzanne E;
Moreau, Lisa A;
Byers, Richard J;
Christensen, James G;
Woude, George Vande;
Licht, Jonathan D;
Kung, Andrew L;
Staudt, Louis M;
Look, A Thomas

Publication type:

Article

HER3 and mutant EGFR meet MET.

Published in:

Nature Medicine, 2007, v. 13, n. 6, p. 675, doi. 10.1038/nm0607-675

By:

Arteaga, Carlos L.

Publication type:

Article

The MET Oncogene Network of Interacting Cell Surface Proteins.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 24, p. 13692, doi. 10.3390/ijms252413692

By:

Gallo, Simona;
Folco, Consolata Beatrice;
Crepaldi, Tiziana

Publication type:

Article

KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.

Published in:

Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01667-x

By:

Rosell, Rafael;
Jantus-Lewintre, Eloisa;
Cao, Peng;
Cai, Xueting;
Xing, Baojuan;
Ito, Masaoki;
Gomez-Vazquez, Jose Luis;
Marco-Jordán, Mireia;
Calabuig-Fariñas, Silvia;
Cardona, Andrés Felipe;
Codony-Servat, Jordi;
Gonzalez, Jessica;
València-Clua, Kevin;
Aguilar, Andrés;
Pedraz-Valdunciel, Carlos;
Dantes, Zahra;
Jain, Anisha;
Chandan, S;
Molina-Vila, Miguel Angel;
Arrieta, Oscar

Publication type:

Article

Induction of tumor initiation is dependent on CD44s in c-Met<sup>+</sup> hepatocellular carcinoma.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1166-4

By:

Hien Dang;
Steinway, Steven N.;
Wei Ding;
Rountree, Carl B.

Publication type:

Article

Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1064-9

By:

Brandes, Franziska;
Schmidt, Katharina;
Wagner, Christine;
Redekopf, Julia;
Jürgen Schlitt, Hans;
Geissler, Edward Kenneth;
Lang, Sven Arke

Publication type:

Article

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-185

By:

Kanteti, Rajani;
El-Hashani, Essam;
Dhanasingh, Immanuel;
Tretiakova, Maria;
Husain, Aliya N.;
Sharma, Sherven;
Sharma, Jay;
Vokes, Everett E.;
Salgia, Ravi

Publication type:

Article

Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-240

By:

Pomerleau, Véronique;
Landry, Mélissa;
Bernier, Jimmy;
Vachon, Pierre H.;
Saucier, Caroline

Publication type:

Article

HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop.

Published in:

BMC Cancer, 2011, v. 11, n. 1, p. 180, doi. 10.1186/1471-2407-11-180

By:

Syed, Zanobia A.;
Weihong Yin;
Hughes, Kendall;
Gill, Jennifer N.;
Shi, Runhua;
Clifford, John L.

Publication type:

Article

TNF-alpha employs a protein-tyrosine phosphatase to inhibit activation of hepatocyte growth factor receptor and hepatocyte growth factor-induced endothelial cell proliferation.

Published in:

Molecular & Cellular Biochemistry, 2009, v. 322, n. 1/2, p. 113, doi. 10.1007/s11010-008-9946-7

By:

Masahiro Sugano;
Yoshiko Iwasaki;
Masako Abe;
Toyoki Maeda;
Keiko Tsuchida;
Naoki Makino

Publication type:

Article

23rd International Symposium on Radiopharmaceutical Sciences.

Published in:: Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, p. S5, doi. 10.1002/jlcr.3724
Publication type:: Article

Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.

Published in:

Gastric Cancer, 2016, v. 19, n. 1, p. 183, doi. 10.1007/s10120-015-0471-6

By:

Fuse, Nozomu;
Kuboki, Yasutoshi;
Kuwata, Takeshi;
Nishina, Tomohiro;
Kadowaki, Shigenori;
Shinozaki, Eiji;
Machida, Nozomu;
Yuki, Satoshi;
Ooki, Akira;
Kajiura, Shinya;
Kimura, Tetsuo;
Yamanaka, Takeharu;
Shitara, Kohei;
Nagatsuma, Akiko;
Yoshino, Takayuki;
Ochiai, Atsushi;
Ohtsu, Atsushi

Publication type:

Article

Expression of Hepatocyte Growth Factor/Scatter Factor Receptor in IUGR Fetuses Placentas: An Immunohistochemical Analysis.

Published in:

Fetal Diagnosis & Therapy, 2005, v. 20, n. 4, p. 249, doi. 10.1159/000085079

By:

C. Baykal;
G. Güler;
A. Al;
G. Tulunay;
S. Özer;
R. Yencilek;
D. Bülbül;
A. Ayhan

Publication type:

Article

Role of hepatocyte growth factor (HGF)/c?Met signaling pathway in early follicular development in mice.

Published in:

Journal of Practical Medicine / Shiyong Yixue Zazhi, 2023, v. 39, n. 20, p. 2566, doi. 10.3969/j.issn.1006-5725.2023.20.002

By:

Li Mingxing;
Li Zhuoxian;
Li Kangmei;
Chen Xiurong;
Zhou Yanping;
Huang Yulin;
Bai Lin;
Wu Zhansh- Uai;
Xia Meng;
He Guozhen

Publication type:

Article

Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation.

Published in:

Journal of Cell Biology, 2008, v. 182, n. 5, p. 855, doi. 10.1083/jcb.200806076

By:

Kermorgant, Stéphanie;
Parker, Peter J.

Publication type:

Article

c-Met is essential for wound healing in the skin.

Published in:

Journal of Cell Biology, 2007, v. 177, n. 1, p. 151, doi. 10.1083/jcb.200701086

By:

Chmielowiec, Jolanta;
Borowiak, Malgorzata;
Morkel, Markus;
Stradal, Theresia;
Munz, Barbara;
Werner, Sabine;
Wehland, Jürgen;
Birchmeier, Carmen;
Birchmeier, Walter

Publication type:

Article

Modeling restoration of gefitinib efficacy by co‐administration of MET inhibitors in an EGFR inhibitor‐resistant NSCLC xenograft model: A tumor‐in‐host DEB‐based approach.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 11, p. 1396, doi. 10.1002/psp4.12710

By:

Tosca, Elena M.;
Gauderat, Glenn;
Fouliard, Sylvain;
Burbridge, Mike;
Chenel, Marylore;
Magni, Paolo

Publication type:

Article

A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of Savolitinib in Healthy Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 4, p. 424, doi. 10.1002/cpdd.1224

By:

Miah, Kowser;
Vishwanathan, Karthick;
Scarfe, Graeme;
Li, Yan;
Hara, Indira;
Cantarini, Mireille;
Argue, John;
Menakuru, Somasekhar R.

Publication type:

Article